Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Elsevier launches PharmaPendium AI, designed to support faster and more reliable access to regulatory insights for drug development

(NYSE:RELX) The solution transforms how insights are gathered from regulatory data, enabling users to quickly identify critical precedents, anticipate approval issues and avoid costly missteps LOND...

What is the expected adoption rate among pharmaceutical companies and how might this influence RELX's market share and valuation multiples? What is the competitive landscape for AI-driven regulatory insight platforms, and how does Elsevier's offering compare to rivals like Clarivate and IBM? How will the launch of PharmaPendium AI affect RELX's revenue growth and earnings forecasts?
Symbol: RELX
Product launch
11 days ago
Read more prnewswire

NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit with the Schall Law Firm

(NASDAQ:NUTX) LOS ANGELES, Sept. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nutex Health Inc. ("...

Could this litigation affect Nutex’s ability to raise capital, maintain partnerships, or impact its operational outlook? What short‑term impact could the lawsuit have on NUTX’s share price volatility and trading volume? How likely is a settlement or judgment, and what is the estimated financial exposure for Nutex Health?
Symbol: NUTX
Lawsuits
11 days ago
Read more prnewswire

PUBM Investors Have Opportunity to Lead PubMatic, Inc. Securities Fraud Lawsuit with the Schall Law Firm

(NASDAQ:PUBM) LOS ANGELES, Sept. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PubMatic, Inc. ("Pub...

When are the key upcoming litigation milestones (e.g., hearings, disclosures) that could affect market sentiment? What is the potential financial exposure or settlement cost if the company is found liable? How will the securities fraud lawsuit impact PubM’s stock price in the short term?
Symbol: PUBM
Lawsuits
11 days ago
Read more prnewswire

Dundee Precious Metals Completes Acquisition of Adriatic Metals and Confirms Name Change and ASX Listing

(DPM) TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX:DPM) (“DPM”) is pleased to announce the completion of its previously announced acquisition (the “Acquisition”) o...

How might the name change and ASX listing impact the company's valuation, share liquidity, and investor perception in the short and medium term? What synergies or cost efficiencies does DPM expect to achieve from integrating Adriatic Metals, and how will these be reflected in earnings guidance? How will the acquisition of Adriatic Metals' Vareš operation affect Dundee Precious Metals' production forecasts and cash flow?
Symbol: DPM
Mergers
11 days ago
Read more globenewswire

Jyske Realkredit explores the possibilities of issuing a new euro denominated benchmark covered bond

(JYSK) To Nasdaq Copenhagen A/S                        3rd of September 2025                                         Announcement no. 74/2025

Could this issuance influence Jyske's credit rating, liquidity, and consequently the valuation of its equity (JYSK) in the short‑to‑medium term? What is the expected size, maturity profile, and pricing of the new covered bond, and how might it impact supply‑demand dynamics in the euro covered‑bond market? How will the potential issuance of a euro‑denominated benchmark covered bond affect Jyske Realkredit's funding costs and spread relative to peers?
Symbol: JYSK
Bond issuance
11 days ago
Read more globenewswire

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm

(NASDAQ:REPL) LOS ANGELES, Sept. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Replimune Group, Inc...

When is a key litigation milestone (e.g., a motion filing or a possible settlement) expected that could move the stock? What is the estimated potential financial exposure or settlement cost for Replimune Group, Inc. from this case? How will the ongoing securities fraud lawsuit affect REPL's short-term price volatility?
Symbol: REPL
Lawsuits
11 days ago
Read more prnewswire